Topical Insulin for Glaucoma (TING2) | MicrobiomeTrials← Back to trialsNCT07619482
Topical Insulin for Glaucoma (TING2)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2028-10
Enrollment target: 90 participants Locations- Byers Eye Institute at Stanford University, Palo Alto, California, United States
Other microbiome trials you might be interested in
Glaucoma, Open-Angle
The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yi…
Baltimore, United StatesEst. completion Jan 31, 2028
Primary Open Angle Glaucoma or Ocular Hypertension
The purpose of this study is to collect data about how Rhopressa affects IOP in patients who have had an SLT procedure i…
Jacksonville, United StatesEst. completion Jul 31, 2026
Primary Open Angle Glaucoma
The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical…
Irvine, United StatesEst. completion Jun 2028